Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short.
We’re ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world’s largest gene therapy manufacturing capacity. We’re collaborating with health networks and payers, rethinking pricing models for revolutionary new treatments in development. We are in a daily race to transform genetic understanding into genetic medicine. Because every day is an opportunity to save lives stolen by rare disease.
Armed with the most advanced science in genetic medicine, we are in a daily race to rescue lives otherwise stolen by rare disease. At Sarepta, every day is another twenty-four hours to stand up for patients, advance technology, challenge convention, and drag tomorrow into today.
Sarepta's senior leadership team and board of directors are comprised of industry veterans, each passionately committed to Sarepta's mission to rescue lives otherwise stolen by rare disease.
At Sarepta, our work extends beyond the research and development of medicines. We’re also committed to engaging with and supporting the rare disease communities that we serve by providing patients and their families educational resources and information through advocacy and educational programs.
At Sarepta, we’re doing everything we can to bring precision genetic medicine to individuals and families affected by rare diseases. This includes support through our corporate giving programs for:
Sarepta, a global biopharmaceutical company, has locations throughout the world.